Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


1 Am J Gastroenterol
1 Arch Virol
1 Dig Dis Sci
3 Gastroenterology
1 Hepatology
1 J Hepatol
1 J Infect Dis
7 J Viral Hepat
1 Pediatr Infect Dis J
3 PLoS One
1 Transplantation
1 Vaccine

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. FALADE-NWULIA O, Seaberg EC, Snider AE, Rinaldo CR, et al
    Outcomes of acute hepatitis B virus (HBV) in HIV infection with and without HBV-active antiretroviral therapy.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96487.
    PubMed         Abstract available

  2. DES JARLAIS DC, Duong Thi H, Khuat Thi Hai O, Feelemyer JP, et al
    Ending an HIV epidemic among persons who inject drugs (PWID) in a middle-income country: extremely low HIV incidence among PWID in Hai Phong, Viet Nam.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002712.
    PubMed         Abstract available

    Am J Gastroenterol

  3. TOSETTI G, Degasperi E, Farina E, D'Ambrosio R, et al
    Decompensation in Direct-Acting Antiviral Cured Hepatitis C Virus Compensated Patients With Clinically Significant Portal Hypertension: Too Rare to Warrant Universal Beta-Blocker Therapy.
    Am J Gastroenterol. 2021 Feb 18. pii: 00000434-900000000-98881.
    PubMed         Abstract available

    Arch Virol

  4. BOGLIONE L, De Benedetto I, Lupia T, Cusato J, et al
    Serological and virological response in patients with hepatitis B virus genotype E treated with entecavir or tenofovir: a prospective study.
    Arch Virol. 2021 Feb 12. pii: 10.1007/s00705-021-04992.
    PubMed         Abstract available

    Dig Dis Sci

  5. JONES BE, Allegretti AS, Pose E, Mara KC, et al
    Renal Replacement Therapy for Acute Kidney Injury in Severe Alcohol-Associated Hepatitis as a Bridge to Transplant or Recovery.
    Dig Dis Sci. 2021 Feb 19. pii: 10.1007/s10620-021-06864.
    PubMed         Abstract available


  6. BAZINET M, Pantea V, Placinta G, Moscalu I, et al
    Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naive to Nucleos(t)ide Therapy.
    Gastroenterology. 2020;158:2180-2194.
    PubMed         Abstract available

  7. MITCHELL T, Dolcet A, Lewis D
    Between a Lift and a Hard Place.
    Gastroenterology. 2020;158:2063-2065.

  8. GEHRKE N, Schattenberg JM
    Metabolic inflammation - a role for hepatic inflammatory pathways as driver of comorbidities in non-alcoholic fatty liver disease (NAFLD)?
    Gastroenterology. 2020 Feb 14. pii: S0016-5085(20)30230.
    PubMed         Abstract available


  9. MANDORFER M, Kozbial K, Schwabl P, Chromy D, et al
    Changes in HVPG predict hepatic decompensation in patients who achieved SVR to IFN-free therapy.
    Hepatology. 2019 Jul 31. doi: 10.1002/hep.30885.
    PubMed         Abstract available

    J Hepatol

  10. CAPRARU C, Feld JJ
    Remaining challenges in HCV elimination.
    J Hepatol. 2021 Feb 12. pii: S0168-8278(20)33845.

    J Infect Dis

  11. CHUAYPEN N, Jinato T, Avihingsanon A, Chirapongsathorn S, et al
    Improvement of Gut Diversity and Composition after Direct-Acting Antivirals in HCV-Infected Patients with or without HIV Coinfection.
    J Infect Dis. 2021 Feb 17. pii: 6141513. doi: 10.1093.
    PubMed         Abstract available

    J Viral Hepat

  12. GUZELBULUT F, Gokcen P, Can G, Adali G, et al
    Validation of the HCC-RESCUE Score to Predict Hepatocellular Carcinoma Risk in Caucasian Chronic Hepatitis B Patients Under Entecavir or Tenofovir Therapy.
    J Viral Hepat. 2021 Feb 15. doi: 10.1111/jvh.13485.
    PubMed         Abstract available

  13. FRAZZONI L, Sikandar U, Mazzella G, Fuccio L, et al
    A multimedia multilanguage web-based platform can assess and increase the awareness on HCV infection of Pakistani people living in Italy.
    J Viral Hepat. 2021 Feb 15. doi: 10.1111/jvh.13486.
    PubMed         Abstract available

  14. TOKUCHI Y, Suda G, Kimura M, Maehara O, et al
    Changes in the estimated renal function after hepatitis C virus eradication with direct-acting antiviral agents: Impact of changes in skeletal muscle mass.
    J Viral Hepat. 2021 Feb 15. doi: 10.1111/jvh.13484.
    PubMed         Abstract available

  15. BANDERA A, Lorenzini P, Taramasso L, Cozzi-Lepri A, et al
    The impact of DAA-mediated HCV eradication on CD4(+) and CD8(+) T lymphocyte trajectories in HIV/HCV coinfected patients: data from the ICONA Foundation Cohort.
    J Viral Hepat. 2021 Feb 18. doi: 10.1111/jvh.13488.
    PubMed         Abstract available

  16. VEGAS JJ, Flores-Herrera J, Latasa P, Garrido-Estepa M, et al
    Reduction in hepatitis C-related hospitalisations after the implementation of the Strategic Plan for Tackling Hepatitis C in the Spanish National Health System: regional level differences.
    J Viral Hepat. 2021 Feb 18. doi: 10.1111/jvh.13491.
    PubMed         Abstract available

  17. SHIMAKAWA Y, Vernoux L, Gabassi A, Mercier-Delarue S, et al
    Analytical validation of hepatitis B core-related antigen (HBcrAg) using dried blood spots (DBS).
    J Viral Hepat. 2021 Feb 17. doi: 10.1111/jvh.13489.
    PubMed         Abstract available

  18. HARNEY BL, Brereton R, Whitton B, Pietrzak D, et al
    Hepatitis C treatment in a co-located mental health and alcohol and drug service using a nurse-led model of care.
    J Viral Hepat. 2021 Feb 17. doi: 10.1111/jvh.13487.
    PubMed         Abstract available


  19. MOFFAT GT, Ren Z, Simone AA
    An 18-Month History of Dorsal Foot Lesions.
    JAMA. 2021;325:579-580.

    Pediatr Infect Dis J

  20. BRISCA G, Mallamaci M, Tardini G, Martino L, et al
    SARS-CoV-2 Infection May Present as Acute Hepatitis in Children.
    Pediatr Infect Dis J. 2021 Feb 9. pii: 00006454-900000000-95873.

    PLoS One

  21. TESFA T, Hawulte B, Tolera A, Abate D, et al
    Hepatitis B virus infection and associated risk factors among medical students in eastern Ethiopia.
    PLoS One. 2021;16:e0247267.
    PubMed         Abstract available

  22. GRUBYTE S, Urboniene J, Nedzinskiene L, Jelinskaite A, et al
    Prevalence, incidence and residual risk of transfusion transmitted viruses (HBV, HCV and HIV infections) in Lithuanian blood donors from 2004 to 2018: The incidence/window-period model study.
    PLoS One. 2021;16:e0246704.
    PubMed         Abstract available

  23. MUHLBACHER AC, Sadler A
    Comment on the paper "Cost-effectiveness of sofosbuvir in hepatitis C genotype 1 infection in Germany: A reanalysis of published results".
    PLoS One. 2021;16:e0245480.


    Ribavirin to the Rescue: Natural Killer Cell Function After Hepatitis C Virus Treatment in Liver Transplant Recipients.
    Transplantation. 2021 Feb 12. pii: 00007890-900000000-95359.


  25. KHETSURIANI N, Zaika O, Chitadze N, Slobodianyk L, et al
    Seroprevalence of hepatitis B virus infection markers among children in Ukraine, 2017.
    Vaccine. 2021 Feb 11. pii: S0264-410X(21)00133.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.